Literature DB >> 19379470

Twenty-four-month update on double-kissing crush stenting of bifurcation lesions.

Shao-Liang Chen1, Tak W Kwan.   

Abstract

A group of 312 patients who underwent percutaneous coronary intervention for bifurcation lesions at 12 centers in China, Singapore, Thailand, Israel, India, and Japan were enrolled in a prospective, randomized DKCRUSH-1 trial. The goal of the study was to compare the double kissing (DK) crush technique with the classical crush stenting technique. This study was carried out to determine the differences in the rates of final kissing balloon inflations (FKBI) and the long-term clinical outcomes. The 8-month results of the DKCRUSH-1 study have been previously reported. Here, we present several subgroups analysis and a 24-month clinical update. The results confirmed a sustained, lower MACE rate at 24 months with the double kissing (DK) crush stenting technique compared with that for the classical crush stenting technique (18.1% vs. 29.9%, p = 0.044).

Entities:  

Mesh:

Year:  2009        PMID: 19379470     DOI: 10.1111/j.1540-8183.2009.00440.x

Source DB:  PubMed          Journal:  J Interv Cardiol        ISSN: 0896-4327            Impact factor:   2.279


  3 in total

Review 1.  Recent perspective on coronary artery bifurcation interventions.

Authors:  Debabrata Dash
Journal:  Heart Asia       Date:  2014-02-14

2.  "DK Crush" Technique for a Tightly Stenosed Conjoined SVG Lesion in a Patient with Acute Coronary Syndrome and Cardiogenic Shock.

Authors:  Kuan-Ju Chen; Wen-Lieng Lee; Tsun-Jui Liu; Wei-Chun Chang; Kuo-Yang Wang; Chieh-Shou Su
Journal:  Acta Cardiol Sin       Date:  2015-05       Impact factor: 2.672

3.  Percutaneous Coronary Intervention in Patients Without Acute Myocardial Infarction in China: Results From the China PEACE Prospective Study of Percutaneous Coronary Intervention.

Authors:  Yuan Lu; Haibo Zhang; Yongfei Wang; Tianna Zhou; John Welsh; Jiamin Liu; Wenchi Guan; Jing Li; Xi Li; Xin Zheng; John A Spertus; Frederick A Masoudi; Harlan M Krumholz; Lixin Jiang
Journal:  JAMA Netw Open       Date:  2018-12-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.